In many offices, the use of personal cell phones is strictly prohibited, but at the McGill University Health Centre (MUHC), a Bring Your Own Device (BYOD) initiative has been vitally embraced. Launched as a pilot project in 2009, the MUHC provides clinicians and nurses with online software allowing them to quickly access important information related to their patients via a personal smartphone.
Over two years into construction of the McGill University Health Centre’s (MUHC) Glen Site, work has progressed quickly, and the exterior of the facility is now complete. With more than 1,400 workers on site daily, the interior of this future 220,000 m2 is now the focus, as the masonry, electrical, and plumbing for each of the buildings are all underway. Several key pieces of equipment such as sterilizers and linear accelerators are also en route to their new home at the Glen.
For the McGill University Health Centre’s (MUHC) 615 researchers, the new Centre for Innovative Medicine (CIM) at the Glen will house the latest technology available to the scientific world. Located on the fourth floor of the Research Institute, this 50,000 sq. ft. space will be the hub for clinical research at the MUHC, and its medical professionals will conduct investigator-initiated research, first-in-man studies, large-scale clinical trials and vaccine studies.
The McGill University Health Centre (MUHC) Foundation is proud to announce that the first annual Toonie Challenge raised $14,012 in support of The Best Care for Life Campaign. Launched in collaboration with the Quebec Association of Independent Schools (QAIS), students collected toonies for the MUHC Foundation with a long-term objective of raising 69,000 toonies to circle the entire Glen site if placed end-to-end.
The goal of the Toonie Challenge is for students in Montreal schools to collect toonies for the MUHC Foundation, to raise awareness of the needs of the hospital, and to engage students and their schools in an active relationship with the MUHC.
All funds raised this year will go towards completing the MUHC's Best Care for Life Campaign, which supports the building of the new Glen hospital facility that will be completed in the fall of 2014.
McGill University, the McGill University Health Centre, the Jewish General Hospital and St. Mary’s Hospital Center today announced a major collaboration with a leading philanthropic foundation to contribute to the province’s commitment to enhance cancer care. This initiative, the Rossy Cancer Network (RCN), aims to improve quality of care and patient satisfaction, increase survival rates and reduce the burden of cancer.
On Thursday, August 8, 2013, join the McGarrigle and Wainwright families as they unite in Kate’s hometown of Outremont for a special benefit concert in support of The Kate McGarrigle Fund at the McGill University Health Centre (MUHC) Foundation. Back-to-back concerts will be performed at Théâtre Outremont (1248 Bernard Avenue West), with the first beginning at 6:30 p.m., and a second show starting at 9:30 p.m.
Timely screening and diagnosis is critical to the success of new treatments and ultimately to the survival of hepatitis C patients. A new study led by the Research Institute of the McGill University Health Centre (RI MUHC) is the first to show that hepatitis C rapid and point of care tests with a quick turnaround time are highly accurate and reliable as conventional first-line laboratory tests. This head-to-head analysis, published in the current issue of the Annals of Internal Medicine, will lead to changes in screening practices and ultimately impact the control of hepatitis C infection worldwide.
A new discovery that sheds light on the genetic makeup of ovarian cancer cells could explain why some women survive longer than others with this deadly disease. A multi-disciplinary team led by the Research Institute of the McGill University Health Centre (RI MUHC), in collaboration with the Lady Davis Institute of the Jewish General Hospital and the University of Montreal Hospital Research Centre, has identified genetic patterns in ovarian cancer tumours that help to differentiate patients based on the length of their survival after initial surgery. The study was published in the journal PLOS ONE.
Vitamin B12 is essential to human health. However, some people have inherited conditions that leave them unable to process vitamin B12. As a result they are prone to serious health problems, including developmental delay, psychosis, stroke and dementia. An international research team recently discovered a new genetic disease related to vitamin B12 deficiency by identifying a gene that is vital to the transport of vitamin into the cells of the body. This discovery will help doctors better diagnose this rare genetic disorder and open the door to new treatments. The findings are published in the journal Nature Genetics.